735 related articles for article (PubMed ID: 17619064)
1. Salt formation to improve drug solubility.
Serajuddin AT
Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
[TBL] [Abstract][Full Text] [Related]
2. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
David SE; Timmins P; Conway BR
Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
[TBL] [Abstract][Full Text] [Related]
3. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
Elder DP; Holm R; Diego HL
Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
[TBL] [Abstract][Full Text] [Related]
4. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.
Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ
Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605
[TBL] [Abstract][Full Text] [Related]
5. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
Tarsa PB; Towler CS; Woollam G; Berghausen J
Eur J Pharm Sci; 2010 Sep; 41(1):23-30. PubMed ID: 20553863
[TBL] [Abstract][Full Text] [Related]
6. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
He Y; Orton E; Yang D
J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
[TBL] [Abstract][Full Text] [Related]
7. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.
Li S; Wong S; Sethia S; Almoazen H; Joshi YM; Serajuddin AT
Pharm Res; 2005 Apr; 22(4):628-35. PubMed ID: 15846471
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental pH modulation in solid dosage forms.
Badawy SI; Hussain MA
J Pharm Sci; 2007 May; 96(5):948-59. PubMed ID: 17455349
[TBL] [Abstract][Full Text] [Related]
9. Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
Korn C; Balbach S
Eur J Pharm Sci; 2014 Jun; 57():257-63. PubMed ID: 24036162
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
Zannou EA; Ji Q; Joshi YM; Serajuddin AT
Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.
Cavanagh KL; Maheshwari C; Rodríguez-Hornedo N
J Pharm Sci; 2018 Jan; 107(1):113-120. PubMed ID: 29097226
[TBL] [Abstract][Full Text] [Related]
12. Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts.
He Y; Ho C; Yang D; Chen J; Orton E
J Pharm Sci; 2017 May; 106(5):1190-1196. PubMed ID: 28153596
[TBL] [Abstract][Full Text] [Related]
13. Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship.
Völgyi G; Baka E; Box KJ; Comer JE; Takács-Novák K
Anal Chim Acta; 2010 Jul; 673(1):40-6. PubMed ID: 20630176
[TBL] [Abstract][Full Text] [Related]
14. Salt disproportionation: A material science perspective.
Thakral NK; Kelly RC
Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
[TBL] [Abstract][Full Text] [Related]
15. Disproportionation of Pharmaceutical Salts: pH
Avdeef A
Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
[TBL] [Abstract][Full Text] [Related]
16. Crystallization of a salt of a weak organic acid and base: solubility relations, supersaturation control and polymorphic behavior.
Jones HP; Davey RJ; Cox BG
J Phys Chem B; 2005 Mar; 109(11):5273-8. PubMed ID: 16863194
[TBL] [Abstract][Full Text] [Related]
17. Salt Solubility and Disproportionation - Uses and Limitations of Equations for pH
Avdeef A; Sugano K
J Pharm Sci; 2022 Jan; 111(1):225-246. PubMed ID: 34863819
[TBL] [Abstract][Full Text] [Related]
18. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database.
Paulekuhn GS; Dressman JB; Saal C
J Med Chem; 2007 Dec; 50(26):6665-72. PubMed ID: 18052022
[TBL] [Abstract][Full Text] [Related]
19. Impact of mixed counter ion on saturation solubility of esylate salt of a weak basic drug to formulate physically stable and non-hemolytic ready to use injectable solution.
Dalwadi G; Sun Y; Wang L; Shick J; Hicks K; Lam S; Tuliani V; Patel K
Int J Pharm; 2019 Dec; 572():118829. PubMed ID: 31715348
[TBL] [Abstract][Full Text] [Related]
20. In situ salt screening--a useful technique for discovery support and preformulation studies.
Tong WQ; Whitesell G
Pharm Dev Technol; 1998 May; 3(2):215-23. PubMed ID: 9653759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
